Skip to content

Effects of telerehabilitation with different intervention time in patients after percutaneous coronary intervention

Effects of telerehabilitation with different intervention time in patients after percutaneous coronary intervention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043513
Enrollment
Unknown
Registered
2021-02-21
Start date
2021-02-21
Completion date
Unknown
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Group A:Intervention started one week after surgery
Group B:Intervention started two week after surgery
Group C:Intervention started four week after surgery

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Subjects diagnosed with coronary heart disease and successfully completed percutaneous coronary intervention. 2. The subjects were 18 years old or older. 3. The hemodynamics and vital signs of the subjects were stable. 4. The subjects have received standardized optimal drug treatment for heart disease and other complications. 5. The subjects have smart phones and good communication and cooperation ability, without obvious cognitive impairment. 6. The physical condition of the subjects is suitable for regular exercise. 7. The subjects are willing to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. The subjects were unable to operate the smart phone for the experiment (such as visual, hearing, cognitive and other obstacles), or the subjects' residence did not have Internet access; 2. The subjects had severe physical disability that they could not complete routine exercise; 3. Subjects with unstable heart conditions (such as decompensated heart failure, NYHA class IV, severe arrhythmia, etc.); 4. Subjects with uncontrolled hypertension, diabetes, chronic obstructive pulmonary disease and other complications. 5. Subjects with new clinical manifestations (such as new arrhythmia, ECG ST segment change, dyspnea intolerance, obvious fatigue intolerance) during exercise evaluation; 6. The subjects showed signs of severe arrhythmia or hemodynamic deterioration on echocardiography.

Design outcomes

Primary

MeasureTime frame
Six Minute Walk Test;Duke Activity Status Index;

Secondary

MeasureTime frame
Cardio Pulmonary Exercise Testing;30-second Chair Stand Test;Grip;Berg Balance Scale;12-Item Short Form Survey;Seattle Angina Questionnaire;Self-rating?Depression?Scale;Self-Rating Anxiety Scale;Pittsburgh sleep quality index;

Countries

China

Contacts

Public ContactQuan Wei

West China Hospital of Sichuan University

weiquan@scu.edu.cn+86 18980606730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026